These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 18175394)
41. Genetics of Parkinson's disease. Bonifati V Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis and treatment of Parkinson disease: molecules to medicine. Savitt JM; Dawson VL; Dawson TM J Clin Invest; 2006 Jul; 116(7):1744-54. PubMed ID: 16823471 [TBL] [Abstract][Full Text] [Related]
43. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. Kanthasamy A; Jin H; Mehrotra S; Mishra R; Kanthasamy A; Rana A Neurotoxicology; 2010 Sep; 31(5):555-61. PubMed ID: 20005250 [TBL] [Abstract][Full Text] [Related]
44. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Lev N; Melamed E; Offen D Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840 [TBL] [Abstract][Full Text] [Related]
45. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Zhang Y; Dawson VL; Dawson TM Neurobiol Dis; 2000 Aug; 7(4):240-50. PubMed ID: 10964596 [TBL] [Abstract][Full Text] [Related]
46. Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease. Raichur A; Vali S; Gorin F Neuroscience; 2006 Oct; 142(3):859-70. PubMed ID: 16920272 [TBL] [Abstract][Full Text] [Related]
48. What causes cell death in Parkinson's disease? Gupta A; Dawson VL; Dawson TM Ann Neurol; 2008 Dec; 64 Suppl 2(0 2):S3-15. PubMed ID: 19127586 [TBL] [Abstract][Full Text] [Related]
49. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease. Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011 [TBL] [Abstract][Full Text] [Related]
55. Measurement of proteasomal dysfunction in cell models of dopaminergic degeneration. Sun F; Kanthasamy AG; Kanthasamy A Methods Mol Biol; 2011; 758():293-305. PubMed ID: 21815074 [TBL] [Abstract][Full Text] [Related]
56. Disruption of protein quality control in Parkinson's disease. Cook C; Stetler C; Petrucelli L Cold Spring Harb Perspect Med; 2012 May; 2(5):a009423. PubMed ID: 22553500 [TBL] [Abstract][Full Text] [Related]